Scarica l'app Stockscreener
4.85
3.63%
0.17
Larimar Therapeutics Inc Azioni (LRMR) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
78.11%
49.50
|
27.79 | 31.19 | 31.29 | 18.26 |
| Operating Income/Loss |
78.11%
-49.50
|
-27.79 | -31.19 | -31.29 | -18.26 |
| Nonoperating Income/Loss |
10.99%
1.787
|
1.61 | 1.907 | 2.469 | 2.765 |
| Income/Loss From Continuing Operations Before Tax |
82.23%
-47.71
|
-26.18 | -29.28 | -28.82 | -15.50 |
| Income Tax Expense/Benefit |
-
|
- | - | - | - |
| Income/Loss From Continuing Operations After Tax |
82.23%
-47.71
|
-26.18 | -29.28 | -28.82 | -15.50 |
|
Net Income/Loss
|
82.23%
-47.71
|
-26.18 | -29.28 | -28.82 | -15.50 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
22.33%
78.32
|
64.03 | 63.96 | 0.8564 | 63.81 |
| Diluted Average Shares |
22.33%
78.32
|
64.03 | 63.96 | 0.8564 | 63.81 |
| Basic Earnings Per Share |
48.78%
-0.61
|
-0.41 | -0.46 | -0.46 | -0.24 |
| Diluted Earnings Per Share |
48.78%
-0.61
|
-0.41 | -0.46 | -0.46 | -0.24 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
0.04%
0.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):